Letter: adoption of uniform nomenclature is crucial for estimating the true risk of HBV reactivation in patients treated with direct ‐acting antivirals for hepatitis C

Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1573-1574, June 2018.

Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: M. M. M ücke , V. T. Mücke , J. Vermehren Source Type: research